Skip to main content

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

05 Nov 2026 Evaluate
The revenue zoomed 21.27% to Rs. 34820.00 millions for the quarter ended September 2026 as compared to Rs. 28712.00 millions during the corresponding quarter last year.Profit after Tax for the quarter ended September 2026 saw a decline of -38.22% from Rs. 11566.00 millions to Rs. 7145.00  millions.Operating Profit reported a sharp decline to 12208.00 millions from 16934.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 34820.00 28712.00 21.27 63542.00 54595.00 16.39 114840.00 151163.00 -24.03
Other Income 1646.00 5415.00 -69.60 2883.00 6986.00 -58.73 28962.00 9058.00 219.74
PBIDT 12208.00 16934.00 -27.91 19315.00 24359.00 -20.71 55929.00 84325.00 -33.67
Interest 1014.00 1138.00 -10.90 2045.00 2514.00 -18.66 4829.00 4639.00 4.10
PBDT 11175.00 15796.00 -29.25 17251.00 21845.00 -21.03 49431.00 79686.00 -37.97
Depreciation 1554.00 1360.00 14.26 3073.00 2660.00 15.53 5612.00 5239.00 7.12
PBT 9621.00 14436.00 -33.35 14178.00 19185.00 -26.10 43819.00 74447.00 -41.14
TAX 2476.00 2870.00 -13.73 3637.00 3772.00 -3.58 8221.00 16698.00 -50.77
Deferred Tax -16.00 53.00 -130.19 -32.00 59.00 -154.24 -777.00 873.00 -189.00
PAT 7145.00 11566.00 -38.22 10541.00 15413.00 -31.61 35598.00 57749.00 -38.36
Equity 998.00 1006.00 -0.80 998.00 1006.00 -0.80 1006.00 1006.00 0.00
PBIDTM(%) 35.06 58.98 -40.55 30.40 44.62 -31.87 48.70 55.78 -12.70
Peers
Company Name CMP
Sun Pharma. Inds. 1882.15
Dr. Reddys Labs. 1386.30
Cipla 1407.05
Lupin 2014.50
Zydus Lifesciences 1199.65
View more..